跳至主要内容
临床试验/NCT07292376
NCT07292376Enrolling By Invitation不适用

Implementing VTE Prevention in Ambulatory Cancer Care

University of Vermont2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2025年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
25
试验地点
2
主要终点
Documented VTE risk assessment

研究概览

简要总结

assess effectiveness of a , compared with usual care, to assess

The goal of this study is to learn if a modified clinical program can improve adherence to guideline recommendations for prevention of venous thromboembolism in ambulatory patients with cancer. The main question[s] it aims to answer are:

Does the modified program improve number of ambulatory oncology patients starting systemic treatment getting VTE risk-assessment? Does the modified program improve the number of patients receiving appropriate preventative anticoagulation? Researchers will compare to usual care (no clinical program).

Participant clinicians will be asked to

  • receive education about VTE prevention recommendations
  • carry out risk assessment, anticoagulation discussions, and document the results Participant patients will receive care from clinicians participating in the study as part of their cancer care.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinicians: practicing oncologist at study clinic site (UVMMC)
  • Patients: diagnosis of cancer; starting new systemic cancer-directed therapy at a study clinic site under the direction of the enrolled clinician

排除标准

  • 未提供

结局指标

主要结局

Documented VTE risk assessment

时间窗: 30 days after new patient appointment

Proportion of new patients who have documented VTE risk assessment

次要结局

  • Appropriate thromboprophylaxis(30 days after new patient appointment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karlyn Martin

Associate Professor of Medicine

University of Vermont

研究点 (2)

Loading locations...

相似试验